Peg-interferon and ribavirin therapy is safe and effective among HCV patients with thalassaemia major

Autor: D’Ambrosio, R., Poggiali, E., Mazzoleni, M., Aghemo, A., Lai, M.E., Cianciulli, P., Colombo, M., Cappellini, M.D.
Zdroj: In Digestive and Liver Disease February 2014 46 Supplement 1:e19-e19
Databáze: ScienceDirect